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Multiple locus variable number tandem repeat analysis 
was performed on 178 Bartonella henselae isolates from 
9 countries; 99 proﬁ  les were distributed into 2 groups. Hu-
man isolates/strains were placed into the second group. 
Genotype I and II isolates shared no common proﬁ  le. All 
genotype I isolates clustered within group B. The evolutive 
implications are discussed.  
B
artonella henselae is the zoonotic agent of cat-scratch 
disease and has been associated with bacillary an-
giomatosis, bacillary peliosis, endocarditis, osteomyelitis, 
and neuroretinitis (1). It is usually present in low numbers 
in infected human tissues, whereas cats, the natural res-
ervoir for the bacterium, are prone to persistent bacter-
emia. Therefore, most B. henselae isolates are of feline 
origin. Two genotypes, based on 16S rDNA differences, 
have been described (1). Genotype I was more frequently 
observed in humans in some countries where most cats 
are infected with genotype II (2,3). Genotype II is more 
prevalent in cats in Europe, Australia, and the United 
States (2–6), and most feline isolates from Asia belong 
to genotype I (7–9). In a recent study, 3 (1.6%) of 191 
B. henselae isolates harbored 2 different 16S rDNA cop-
ies and could not be assigned to a distinct genotype (10). 
However, most isolates harbored 2 identical 16S rDNA 
copies and were assigned to either type I or II, conﬁ  rming 
that delineation of B. henselae isolates in two 16S rDNA 
types is generally reasonable.
Multiple-locus variable number tandem repeat analy-
sis (MLVA) was recently developed for B. henselae typing 
(6). The results are produced in an intrinsically quantitative 
form, called a proﬁ  le, corresponding to the number of basic 
units in an isolate for each variable number tandem repeat 
(VNTR). MLVA was more discriminatory (11) than the 
other widely used typing techniques, such as pulsed-ﬁ  eld 
gel electrophoresis (2), multilocus sequence typing (MLST) 
(12) and multispacer typing (MST) (13). In our protocol, 
MLVA involves the ampliﬁ  cation of 5 main VNTR loci, 
BHV-A to -E, for B. henselae VNTRs (6).
The Study
We analyzed 178 B. henselae isolates/strains from var-
ious sources (Table 1): 156 (88%) feline isolates/strains, 
21 (11%) from diseased humans, and 1 isolate from a sick 
dog. The number of alleles varied from 7 (BHV-E) to 22 
(BHV-B). Most of the European isolates (all but 1 of feline 
origin) (2,4,6) and of the American isolates/strains (North 
Carolina and California) (5,14), of which 85% were of fe-
line origin, belonged to genotype II (89% and 64.6%, re-
spectively). The Asian isolates (all but 1 of feline origin) 
(7–9) and the Australasian isolates (60% of human origin) 
(12), mainly belonged to genotype I (89.6% and 65%, re-
spectively). 
Ninety-nine different MLVA proﬁ  les were observed 
(Table 1), corresponding to an average number of isolates 
per proﬁ  le of 1.8 (Table 2). Sixty-nine of these proﬁ  les 
were found in only 1 isolate or strain (67%), and 30 were 
observed in >1 isolate. Among these, none was shared by 
genotype I and genotype II isolates. Diversity index (DI) 
was 0.98 (Table 1). Diversity was observed in both geno-
types because genotype-speciﬁ  c DIs were almost identical 
(Table 1).
MLVA proﬁ   les appeared location-speciﬁ  c  because 
only 4 (13%) of the 30 proﬁ  les observed in >1 isolate/strain 
were present in >1 continent (Table 2). Within continents, 
no marked dominance of a given proﬁ  le was observed, and 
continent-speciﬁ  c DIs were similar (Table 1). 
Of the 99 B. henselae proﬁ  les, 12 were obtained from 
the 21 human isolates/strains and 1 from the dog, whereas 
92 proﬁ  les were obtained from the 156 feline isolates. Five 
proﬁ  les were common to 5 human and 11 feline isolates. 
Among the 30 proﬁ  les observed in >2 isolates, 23 were 
observed only in feline isolates (Table 2). The proportion 
of genotype I proﬁ  les was signiﬁ  cantly higher in human-
speciﬁ  c proﬁ  les than in cat-speciﬁ  c proﬁ  les (p = 0.01, by 
Fisher test).
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found in isolates from humans, whereas all 8 identiﬁ  ed al-
leles were observed in cat isolates. The number of repeats 
differed signiﬁ  cantly between sick humans and healthy cats 
(p = 0.02, by Fisher test).
Relationships between the 99 MLVA proﬁ  les were 
analyzed by unweighted pair group method with arith-
matic mean (UPGMA), using a categorical distance, with 
a B. koehlerae isolate used as an outgroup. To take into 
account that UPGMA is sensitive to taxa entry order, we 
computed the majority-rule consensus tree of 500 dendro-
grams built with random taxa entry order. MLVA proﬁ  les 
were grouped into 2 main groups named A and B (on-
line Appendix Figure, available from www.cdc.gov/EID/
content/15/5/813.htm).  Group A (26 proﬁ  les), was exclu-
sively constituted by genotype II feline isolates. Group 
B (73 proﬁ  les), to which all human isolates belonged, 
further divided in 2 subgroups, Ba and Bb. Subgroup 
Ba (38 proﬁ  les) was exclusively composed of genotype 
I isolates, including the reference strain Houston I and a 
homogenous subgroup, Ba1, containing 84% of the Asian 
isolates. Finally, 83% of subgroup Bb isolates belonged to 
genotype II (29/35 proﬁ  les).
The utility of MLVA for molecular epidemiologic 
analysis of clusters was tested using isolates from Califor-
nia cats and their owners (14). Five human–cat groups of 
B. henselae isolates were analyzed. For 1 cat-human pair of 
isolates, which belonged, respectively, to genotype II and 
genotype I, major proﬁ  le differences were observed, as ex-
pected. The 4 other cat-human groups, which possessed the 
same genotype, also had the same MLVA proﬁ  le with the 
5 tested BHV, as well as with the 6 additional BHV (F–K) 
and variant alleles for BHV-A and/or B (6). Sequencing 
conﬁ  rmed these results.
Conclusions
Our results conﬁ  rm that VNTRs are excellent molecu-
lar markers for conﬁ  rming or excluding the responsibility 
of a given cat in the transmission of B. henselae to a hu-
man. In California, the proﬁ  le identity observed within 4 
clusters further supports the hypothesis that all these hu-
mans acquired infection from their respective domestic cat 
contacts. 
MLVA enabled a clear separation between genotypes 
I and II, because no proﬁ  le was shared between both geno-
types. The dendrogram showed a high level of discrimi-
nation between 16S rDNA genotypes in the B. henselae 
population tested. Interestingly, the groups and subgroups 
delineated by MLVA were the same as those deﬁ  ned by 
MLST, a standard method for phylogenetic analysis (12). 
The same was observed with MST (13). The isolates of the 
subgroup Bb appeared divergent and distant from each oth-
er and from subgroup Ba that contains almost all genotype 
I proﬁ  les (98%). Moreover and despite possible clustering 
for some of the isolates, none of the 21 human isolates was 
present in group A. Interestingly, as for most of the human 
patients, the isolate obtained from the ill dog also belonged 
to genotype I.
These observations suggest that all genotype I isolates 
could be phylogenetically derived from genotype II isolates 
located in group B but not in group A, as already suggested 
using MLST (15). This observation could mean that geno-
type II isolates belonging to group B are closer to genotype 
I isolates than to genotype II isolates belonging to group 
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Table 1. Description of Bartonella henselae isolates and strains tested, global diversity of the typing system, and diversity variations 
according to 16S rDNA genotype, continent, and host* 
No. alleles (minimum–maximum no. repeats) 
Characteristics
No. isolates/ 
strains 
No.
profiles
Average no. 
isolates/profiles DI ABC D E
All B. henselae 178 99 1.8 0.98 8
(9–16)
22
(5–37)
14
(1–25)
8
(1–9)
7
(1–7)
  16S rDNA genotype I  64 44 1.5 0.98 6 12 11 6 6
  16S rDNA genotype II  114 55 2.0 0.97 6 15 7 7 6
Location
 Europe  80† 42 1.9 0.95 6 12 6 6 5
 Asia  29‡ 22 1.3 0.98 7 10 8 4 3
 USA  49§ 28 1.7 0.95 4 12 7 6 6
 Australia–New  Zealand  20¶ 11 1.8 0.87 4 5 5 4 6
Host
  Human + dog  22# 12 1.8 0.87 2 6 6 3 6
 Healthy  cat  156 92 1.7 0.98 8 20 11 8 7
*DI, diversity index; A, BHV-A; B, BHV-B; C, BHV-C; D, BHV-D; E, BHV-E. 
†Denmark, 18 (7); France, 23 (7); Germany, 27 (2); UK, 12 (5).  
‡Japan, 12 (8); Philippines, 7 (9); Thailand, 10 (10).
§California: 36, including 5 owners and their 11 cats (6,14); North Carolina, 12 (provided by Ed Breitschwerdt). Reference strain Houston 1. 
¶Australia, 18 and New Zealand, 2 (3,12).
#21 human isolates from 1 German patient with bacillary angiomatosis (BA) (2), 1 Japanese patient with cat-scratch disease (provided by S. Maruyama), 
12 Australian human patients with cat-scratch disease (3), 5 California human patients with BA (14), 1 North Carolina patient with a wide range of 
symptoms, including fatigue, joint pain, insomnia, headache, blurred vision, irritability (provided by Ed Breitschwerdt), plus the reference strain Houston 1 
(ATCC 49882, initially isolated from a patient with BA) (3), and 1 isolate from a dog with endocarditis (provided by Ed Breitschwerdt). Feline and Human B. henselae Isolates
A; it also raises an important clinical question: Are feline 
genotype II isolates belonging to group A nonpathogenic 
for humans? Genotype I isolates could represent the most 
pathogenic isolates for humans within a group of poten-
tially zoonotic isolates, all belonging to group B and could 
represent an ultimate evolutionary step toward human in-
fection. Additionally, within group B, the differences in the 
number of BHV-A repeat units observed between isolates 
from patients (humans, dog) versus cat isolates suggest that 
this speciﬁ  c VNTR could constitute a marker for the ability 
to cross the species barrier from reservoir cats to suscep-
tible species, independent of the 16S rDNA genotype.
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